ADRB2R gene polymorphism (pol.) associated with the severity of cystic fibrosis(CF) and the effectiveness of the use of inhaled bronchodilator

F. A. D. L. Marson, J. D. Ribeiro, C. S. Bertuzzo, A. F. Ribeiro (Campinas, Brazil)

Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Session: Cystic fibrosis: clinical and laboratory studies
Session type: Thematic Poster Session
Number: 2665
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. A. D. L. Marson, J. D. Ribeiro, C. S. Bertuzzo, A. F. Ribeiro (Campinas, Brazil). ADRB2R gene polymorphism (pol.) associated with the severity of cystic fibrosis(CF) and the effectiveness of the use of inhaled bronchodilator. Eur Respir J 2010; 36: Suppl. 54, 2665

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Repeat polymorphisms (pol.) in the NOS-1 gene and its association with the clinical severity of cystic fibrosis (CF)
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

Lack of effect of promoter, coding and 3‘ polymorphisms of the β2-adrenergic receptor (ADRB2) on the clinical response to salmeterol alone or with fluticasone propionate in subjects with asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

E-cadherin (CDH-1) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS)
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010

The associations of polymorphism C3435T multidrug resistance gene (MDR1) and regimen of inhaled glucocorticosteroid therapy in bronchial asthma (BA) patients
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

The influence of polymorphisms of the β2- adrenoceptor (AR) gene and the β2-AR upstream peptide (BUP) on bronchoprotective tolerance development in asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 515s
Year: 2001

Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity
Source: Virtual Congress 2020 – Genetic and environmental influences on development of asthma and COPD
Year: 2020




Effects of β2 agonists on mucociliary clearance (MCC) in patients with asthma - association to polymorphisms of the β2-adrenoceptor
Source: Eur Respir J 2003; 22: Suppl. 45, 478s
Year: 2003

ADRB2 Gly16Arg polymorphism, asthma control and lung function decline
Source: Eur Respir J 2011; 38: 1029-1035
Year: 2011



A single nucleotide polymorphism in NOD2 gene was associated with pathogenesis and severity of COPD
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010

Association of β2-adrenoreceptor genotype with bronchodilator responses (bdr) in COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

Glucocorticosteroid receptor (GCR) gene isoforms expression in bronchial asthma (BA) patients
Source: Annual Congress 2011 - Asthma: a heterogeneous disease
Year: 2011


Clinical significance of asthma related SNP (single nucleotide polymorphism) in well defined asthma patients
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008


COPD: Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination and oxygen saturation (OS) in patients (pts) with different plasma surfactant protein D (SP-D) level
Source: International Congress 2015 – COPD: notable points
Year: 2015


Polymorphism of β2-adrenergic receptor (β2-AR) and regular use of long-acting β-agonists in asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 341s
Year: 2004

E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids
Source: Eur Respir J 2011; 38: 1044-1052
Year: 2011



Polymorphic variation in surfactant protein B is associated with COPD exacerbations
Source: Eur Respir J 2008; 32: 938-944
Year: 2008



SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response
Source: Eur Respir J 2011; 38: 1036-1043
Year: 2011



Evidence for a non-β2-adrenoceptor (β2AR) binding site in human lung tissue for the long acting β2-agonist (LABA) vilanterol
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012

Association of single nucleotide polymorphisms in 4 genes (VDR, COL1A1, CALCR and BGLAP) with susceptibility to steroid osteoporosis in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011